CORNERSTONE INVESTORS

and Dwyer will be 11,816,000 Shares (rounded down to the nearest whole board lot and
calculated based on the conversion of the investment amount made in US$ being converted at
the rate of US$1.000 to HK$7.8282 for illustrative purposes only), representing approximately
5.00% of the Offer Shares and approximately 1.06% of the Shares in issue immediately upon
completion of the Global Offering, assuming the Over-allotment Option is not exercised and
no shares are issued pursuant to the Equity Plans.

Assuming the Offer Price of HK$14.00 (being the high-end of the Offer Price range set
out in this prospectus), the total aggregate number of Shares to be subscribed for by Seacliff
and Dwyer will be 11,182,500 Shares (rounded down to the nearest whole board lot and
calculated based on the conversion of the investment amount made in US$ being converted at
the rate of US$1.000 to HK$7.8282 for illustrative purposes only), representing approximately
4.73% of the Offer Shares and approximately 1.00% of the Shares in issue immediately upon
completion of the Global Offering, assuming the Over-allotment Option is not exercised and
no shares are issued pursuant to the Equity Plans.

2.

Cormorant Asset Management, LP

Cormorant Asset Management, LP (“Cormorant”) is a SEC registered investment advisor
located in Boston, Massachusetts, USA, which has been providing investment advisory
services since March 2013. Cormorant invest primarily in public and private securities of
healthcare and life sciences companies. Cormorant Global Healthcare Master Fund, LP,
Cormorant Private Healthcare Fund II, LP, and CRMA SPV, LP (the “Cormorant Funds”) are
long-term investment partnerships investing in healthcare and life sciences companies and
advised by Cormorant.

Cormorant has agreed to subscribe for such number of Offer Shares (rounded down to the
nearest whole board lot) which may be purchased for an aggregate amount of US$25,000,000
(or approximately HK$195,705,000 calculated based on the conversion rate of US$1.000 to
HK$7.8282 for illustrative purposes only) at the Offer Price.

Assuming the Offer Price of HK$12.50 (being the low-end of the Offer Price range set out
in this prospectus), the total aggregate number of Shares to be subscribed for by Cormorant will
be 15,656,000 Shares (rounded down to the nearest whole board lot and calculated based on
the conversion of the investment amount made in US$ being converted at the rate of US$1.000
to HK$7.8282 for illustrative purposes only), representing approximately 6.62% of the Offer
Shares and approximately 1.40% of the Shares in issue immediately upon completion of the
Global Offering, assuming the Over-allotment Option is not exercised and no shares are issued
pursuant to the Equity Plans.

Assuming the Offer Price of HK$13.25 (being the mid-point of the Offer Price range set
out in this prospectus), the total aggregate number of Shares to be subscribed for by Cormorant
will be 14,770,000 Shares (rounded down to the nearest whole board lot and calculated based
on the conversion of the investment amount made in US$ being converted at the rate of
US$1.000 to HK$7.8282 for illustrative purposes only), representing approximately 6.25% of
the Offer Shares and approximately 1.32% of the Shares in issue immediately upon completion
of the Global Offering, assuming the Over-allotment Option is not exercised and no shares are
issued pursuant to the Equity Plans.

– 360 –

